LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target

OBJECTIVE: HER2 negative carcinomas of the breast pose a challenge for treatment due to redundancies in potential drug targets and poor patient outcomes. Our aim was to investigate the role of L-type amino acid transporter – LAT1 as a potential prognosticator and a drug target. METHODS: In this retr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Asian Pac J Cancer Prev
Asıl Yazarlar: Bodoor, Khaldon, Almomani, Rowida, Alqudah, Mohammad, Haddad, Yazan, Samouri, Walaa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: West Asia Organization for Cancer Prevention 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541863/
https://ncbi.nlm.nih.gov/pubmed/32458655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.5.1453
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller